TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01418170

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: cervical spinal manipulative therapy
Description: A real cervical spine manipulation will be used for the intervention vs a sham cervical spine manipulation. For the rcSMT the subject's head will be supported by the clinician's forearm. The contact hand of the clinician will contact the C5-C6 spinal segment. A thrust maneuver will be given by the contact hand of the clinician with the supportive hand resting on the subject's zygoma. A rotational inferior drop thrust maneuver will be completed. For the scSMT the subject's head will be rotated to 45 degrees and will be supported by the clinician's forearm, which will lie on top if the headpiece. A thrust maneuver will then be given by the contact hand of the treating clinician to the drop piece with the hand beside the paraspinal musculature simulating a real thrust, the supportive hand will be resting on the subject's zygoma. A inferior drop thrust will be applied to the drop piece (no thrust is made by the contact hand on the cervical spine).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervical spinal manipulative therapy
Description: A real cervical spine manipulation will be used for the intervention vs a sham cervical spine manipulation. For the rcSMT the subject's head will be supported by the clinician's forearm. The contact hand of the clinician will contact the C5-C6 spinal segment. A thrust maneuver will be given by the contact hand of the clinician with the supportive hand resting on the subject's zygoma. A rotational inferior drop thrust maneuver will be completed. For the scSMT the subject's head will be rotated to 45 degrees and will be supported by the clinician's forearm, which will lie on top if the headpiece. A thrust maneuver will then be given by the contact hand of the treating clinician to the drop piece with the hand beside the paraspinal musculature simulating a real thrust, the supportive hand will be resting on the subject's zygoma. A inferior drop thrust will be applied to the drop piece (no thrust is made by the contact hand on the cervical spine).
Study: NCT04286256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Participants/caregivers will receive several telephone-based and in-person motivational interviewing sessions along with specific oral health recommendations.
Study: NCT01370694

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-8808

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisolone
Study: NCT01801293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-5806
Study: NCT02736799

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vibrating capsule
Description: Sham device without vibration
Study: NCT01197378

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cysteamine Bitartrate Delayed-release Capsules
Description: Participants who entered the trial from the RP103-03 study continued treatment with cysteamine bitartrate every 12 hours at the last dose level prescribed during their participation in that study.~Participants not entering the trial from Study RP103-03 were started on twice a day administration of cysteamine bitartrate at a total daily RP103 dose of 70% of their pre-study total daily stable Cystagon® dose.
Study: NCT00833521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg tablets
Description: 1 x 10 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AMBIEN® 10 mg tablets
Description: 1 x 10 mg
Study: NCT02736799

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (1 vibration)
Description: 1 vibration/min

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (3 vibration)
Description: 3 vibration/min

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibrant Capsule (5 vibration)
Description: 5 vibration/min
Study: NCT03775551

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Improvement cycle
Description: at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices.
Study: NCT03094767

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiovascular Rehabilitation
Description: Aerobic and anaerobic exercises performed for 12 weeks, 3x/week, of 60 minutes each.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Initial and Final assessment
Description: Measuring blood preassure, heart rate, Borg scale, respiratory rate, oxygen saturation and HbA1C in the first day of assessment and after 12 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Initial and Final assessment
Description: Measuring blood preassure, heart rate, Borg scale, respiratory rate, oxygen saturation and HbA1C in the first day of assessment and after 12 weeks.
Study: NCT01392872

Intervention type: OTHER
Group type: OTHER
Intervention: Neuropsychological assessment
Description: This study will evaluate the impact of these treatments on cognitive disabilities, tiredness state, emotion and quality of life in general, on a lengthened period.
Study: NCT01367548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Methylnaltrexone (MNTX)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03857334

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Injection of autologous platelet rich plasma
Study: NCT02012101

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: niv plus oxygen therapy
Description: NIV given on Philips Respironics BiPAP Vision apparatus.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: oxygen therapy
Study: NCT01361009

Intervention type: DRUG
Intervention: pramipexole
Description: as prescibed by the investigator
Study: NCT04516174

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block using ropivacaine
Description: Before anesthesia, the ultrasound-guided bilateral transversus abdominis plane block using 0.25% ropivacaine was perdormed by anesthesiologist who is not involved in intraoperative management and postoperative follow-up and evaluate the effect after the block completed.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: After finished the transversus abdominis plane block, then perform tracheal intubation and start the infusion of dexmedetomidine.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Transversus abdominis plane block using saline
Description: Before anesthesia, the ultrasound-guided bilateral transversus abdominis plane block using saline was perdormed by anesthesiologist who is not involved in intraoperative management and postoperative follow-up and evaluate the effect after the block completed.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: After finished the transversus abdominis plane block, then perform tracheal intubation and start the infusion of saline, dosage and infusion method of saline are consistent with dexmedetomidine.
Study: NCT04031092

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Description: traditional inpatient rehabilitation program.
Study: NCT00538291

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Study: NCT03857334

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Injection of cortivazol : Altim®
Description: Corticosteroids
Study: NCT01560728

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy
Description: Individual psychotherapeutic approach occurring once per week for 12 to 20 weeks
Study: NCT04129749

Intervention type: PROCEDURE
Intervention: Real-Time Analysis Interactive Lab
Description: The Real-Time Analysis Interactive Lab uses an instrumented treadmill, a motion capture system (Vicon System), an electromyographic system as well as a virtual environment is projected on a 180 ° screen. This equipment allows patients to walk spontaneously or at prescribed speeds to a standstill in a virtual and secure virtual reality environment.
Study: NCT01810042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ranibizumab
Description: 0.5mg of ranibizumab is injected into the vitreous cavity through pars plana.
Study: NCT03073681

Intervention type: DEVICE
Intervention: Survey
Description: Patients will complete a survey describing their satisfaction with vision after cataract surgery that was performed at least 2 months prior to study enrollment.
Study: NCT04453696

Intervention type: BEHAVIORAL
Intervention: Assessment scales-the Spielberger's State-Trait Anxiety Inventory, Modified Dental Anxiety Scale and a visual analog scale.
Description: STAI-S, like kinetic energy, refers to a palpable reaction or process taking place at a given time and level of intensity. STAI-T, like potential energy, refers to individual differences in reactions. Both of STAI-S and STAI-T scales includes 20 questions. For each question, the scores range from 1 (almost never) to 4 (almost always) points. For both scales, the sum of the scores ranges from 20 to 80. A score between 36 and 41 refers to a mean anxiety level, with values greater than 41 classified as a high level of anxiety.~The MDAS consists of 5 questions that measure anxiety at different stages of dental treatment. The options range from 1 (not anxious) to 5 (very anxious) for each question. The sum of the scores varies from 5 to 25; values between 19 and 25 indicate a high level of dental anxiety.~The VAS scale was included in the present study to determine how anxious the patients felt according to their own thoughts. Scores range from 0 (no anxiety) to 10 (extreme anxiety).

Intervention type: BEHAVIORAL
Intervention: Assessment scales-the Spielberger's State-Trait Anxiety Inventory, Modified Dental Anxiety Scale and a visual analog scale.
Description: STAI-S, like kinetic energy, refers to a palpable reaction or process taking place at a given time and level of intensity. STAI-T, like potential energy, refers to individual differences in reactions. Both of STAI-S and STAI-T scales includes 20 questions. For each question, the scores range from 1 (almost never) to 4 (almost always) points. For both scales, the sum of the scores ranges from 20 to 80. A score between 36 and 41 refers to a mean anxiety level, with values greater than 41 classified as a high level of anxiety.~The MDAS consists of 5 questions that measure anxiety at different stages of dental treatment. The options range from 1 (not anxious) to 5 (very anxious) for each question. The sum of the scores varies from 5 to 25; values between 19 and 25 indicate a high level of dental anxiety.~The VAS scale was included in the present study to determine how anxious the patients felt according to their own thoughts. Scores range from 0 (no anxiety) to 10 (extreme anxiety).
Study: NCT04829513

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise
Description: This is a home exercise programme that involves flexibility and strengthening of the waist, hip girdle and sacroiliac region. These exercises are first shown by the physiotherapist in hospital, and then they are asked to do the exercises at home using illustrated forms. Patients continue the exercises as a home programme once a day for 1 month.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise
Description: This is a home exercise programme that involves flexibility and strengthening of the waist, hip girdle and sacroiliac region. These exercises are first shown by the physiotherapist in hospital, and then they are asked to do the exercises at home using illustrated forms. Patients continue the exercises as a home programme once a day for 1 month.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise
Description: This is a home exercise programme that involves flexibility and strengthening of the waist, hip girdle and sacroiliac region. These exercises are first shown by the physiotherapist in hospital, and then they are asked to do the exercises at home using illustrated forms. Patients continue the exercises as a home programme once a day for 1 month.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ligament Correction Kinesiotaping
Description: Ligament correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lymphatic Correction Kinesiotaping
Description: Lymphatic correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.
Study: NCT02531191

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peficitinib
Description: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peficitinib
Description: oral
Study: NCT02822443

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological therapy (PT) as TAU with integrated emotion focused components (TAU - EFT)
Description: 25 (+/- 3) weekly sessions and up to three booster sessions of face-to-face outpatient psychotherapy; psychological therapy with focus on emotion-focused interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological therapy (PT) as TAU with focus on self-regulation (TAU - SR)
Description: 25 (+/- 3) weekly sessions and up to three booster sessions of face-to-face outpatient psychotherapy; psychological therapy with focus on self-regulation without emotion-focused interventions
Study: NCT00751530

Intervention type: DRUG
Intervention: raltegravir
Description: New combination ART incorporating raltegravir with other ARVs.

Intervention type: DRUG
Intervention: raltegravir
Description: New combination ART incorporating raltegravir with other ARVs.
Study: NCT03545698

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Avizia Telehealth Platform
Description: Avizia will be utilized as a communication tool between home-based caregivers (family members, formal caregivers, or informal caregivers) and the House Calls care management team.
Study: NCT04041076

Intervention type: PROCEDURE
Intervention: Major surgical operation
Description: Surgical operation with magnitude defined as major or ultra-major
Study: NCT03725995

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Patients received 0.5 mg/kg midazolam, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine-Midazolam
Description: Patients received a puff of lidocaine 2% in each nostril, after 60 seconds, they received 0.5 mg/kg midazolam, with a maximum dose of 10 mg. , Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients received saline 9% (placebo), 0.5 mg/kg, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.
Study: NCT04031092

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation program
Description: traditional inpatient rehabilitation program.
Study: NCT05127694

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation
Description: Vestibular Rehabilitation which is consist of repetitive exercises and canalit repositioning maneuvers
Study: NCT01602172

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Alcohol Intervention
Description: 3 part intervention: Part I is 15-minute multi-component motivational discussion in hospital which includes personalized risk feedback, advice to abstain or reduce consumption, and the negotiation of an individual change plan. Part II is 15-minute follow-up in hospital to reinforce Part I. Part III is 15-minute follow-up telephone call at 2 weeks to reinforce Part I.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle brochures
Description: Set of educational brochures/brochures which contain information and tips for healthy lifestyle behaviors such as alcohol and tobacco use, weight management, and physical activity to discuss with the Research Assistant. Approximately two weeks later, the Research Assistant will call patients in this condition at home for a 5-15 minute session to review the brochures and discuss any questions that s(he) may have.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle brochures
Description: Set of educational brochures/brochures which contain information and tips for healthy lifestyle behaviors such as alcohol and tobacco use, weight management, and physical activity to discuss with the Research Assistant. Approximately two weeks later, the Research Assistant will call patients in this condition at home for a 5-15 minute session to review the brochures and discuss any questions that s(he) may have.
Study: NCT02172677

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic memory task

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI
Study: NCT06443359

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: hypofractionated radiation
Description: All patients will receive a dose of 42.56 Gy in 16 daily fractions to the whole breast or chest wall and regional lymph nodes. A boost dose of 10 or 12.5 Gy in 4 or 5 daily fractions of 2.5 Gy, respectively, will be administered to either the lumpectomy cavity or mastectomy scar, as appropriate.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: hypofractionated radiation
Description: All patients will receive a dose of 42.56 Gy in 16 daily fractions to the whole breast or chest wall and regional lymph nodes. A boost dose of 10 or 12.5 Gy in 4 or 5 daily fractions of 2.5 Gy, respectively, will be administered to either the lumpectomy cavity or mastectomy scar, as appropriate.
Study: NCT01445418

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZ2281 + Carboplatin
Description: Cohort 1: Dose escalation: AZD2281 po bid qd + IV carboplatin D8 of each 21-day cycle.; Cohort 2: Expanded cohort treated at the MTD of the combination identified in Cohort 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZ2281 + Carboplatin
Description: Cohort 1: Dose escalation: AZD2281 po bid qd + IV carboplatin D8 of each 21-day cycle.; Cohort 2: Expanded cohort treated at the MTD of the combination identified in Cohort 1.
Study: NCT01482741

Intervention type: BEHAVIORAL
Intervention: Focus Group Sessions
Description: Participants will complete a pre-focus group demographic questionnaire. Focus group participants will be asked to report the following: current age; gender; race/ethnicity; income; highest education attained; occupation; and cancer stage if participant has a cancer history. Participants who are parents of pediatric patients will also report their child's current age, gender, and cancer stage. Ten questions will be developed by the investigators and posed to each group by the moderator to solicit the desired information. The objective for the focus groups will be to systematically explore three domains: 1) what participants know about radiation as it relates to medical imaging; 2) how what they know or believe about radiation shapes their attitudes about it; 3) and participant perceptions regarding the availability and adequacy of their sources, including risk-benefit communication with health care providers

Intervention type: BEHAVIORAL
Intervention: Focus Group Sessions
Description: Participants will complete a pre-focus group demographic questionnaire. Focus group participants will be asked to report the following: current age; gender; race/ethnicity; income; highest education attained; occupation; and cancer stage if participant has a cancer history. Participants who are parents of pediatric patients will also report their child's current age, gender, and cancer stage. Ten questions will be developed by the investigators and posed to each group by the moderator to solicit the desired information. The objective for the focus groups will be to systematically explore three domains: 1) what participants know about radiation as it relates to medical imaging; 2) how what they know or believe about radiation shapes their attitudes about it; 3) and participant perceptions regarding the availability and adequacy of their sources, including risk-benefit communication with health care providers
Study: NCT03246217

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Instrumental Music Performance
Description: Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Instrumental Music Performance
Description: Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.
Study: NCT00643734

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: azithromycin sustained release
Description: azithromycin SR 2.0 g by mouth in the form of a slurry for 1 dose

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: levofloxacin
Description: 500 mg (two 250 mg capsules) by mouth once daily for 7 days

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: placebo
Study: NCT03246217

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Instrumental Music Performance
Description: Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.
Study: NCT04256876

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TTNS
Description: See section 'arms' Stimulation settings: 200 µS, 20 Hz, 1-20 V ( depending of sensory response) Home-therapy: Daily stimulation during 60 minutes.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: TTNS Sham
Description: See section 'arms'
Study: NCT01534910

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aged garlic extract
Description: 2400 mg a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT03175913

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: vapocoolant spray
Description: As a topical pre caudal epidural block anesthesia, spinal needle insertion site was sprayed using an vapocoolant spray for 10-sec from a distance of 30 cm

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local infiltration
Description: As a topical pre caudal epidural block anesthesia, spinal needle insertion site was injected subcutaneously using 3ml of 2% lidocaine